Search clinical trials for: Teen Outreach Program with Media Enhancement (TOP4ME)

Total 18 results

Colorado School of Public Health
Denver Health and Hospital Authority

Completed

Using Social Media to Enhance the Impact of the Teen Outreach Program (TOP4ME)

Pregnancy Prevention

United States
Chapin Hall at the University of Chicago
Chicago Public Schools

Completed

Evaluation of the Teen Outreach Program in Chicago Public Schools

Sexual Behavior
University of South Florida
Florida Department of Health; The Office of Adolescent Health, HHS

Completed

Multi-site Evaluation of an Evidence-based Positive Youth Development Program

Unintended Pregnancy | Adolescent Problem Behavior
Abt Associates
Hennepin County Human Services and Public Health Department

Completed

Evaluation of the Teen Outreach Program in Hennepin County, Minnesota

Sexual Behavior | Pregnancy Early

United States
Philliber Research & Evaluation
The Office of Adolescent Health, HHS; Northwest Coalition of Adolescent Health

Completed

Replication of the Teen Outreach Program in the Pacific Northwest

Teenage Pregnancy
Philliber Research & Evaluation

Completed

Replication of the Teen Outreach Program in Kansas City

Teenage Pregnancy
University of Toronto
University Health Network, Toronto; University of Virginia

Unknown

Contemplation-Based Intervention and Health Outcomes RCT in Lupus Patients

Lupus Erythematosus, Systemic
VA Office of Research and Development

Completed

Home Exercise to Enhance Mobility for Older Diabetics

Diabetes Mellitus Type 2

United States
University Hospital, Bordeaux

Completed

Hyper-synchronicity in Hypertrophic Cardiomyopathy (HCM) : Description, Mechanism and Origin With a Multi-imaging Approach to Predict Dual Chamber Pacing Response (HSYNC)

Hypertrophic Cardiomyopathy | Mechanical Hyper-synchronicity

France
Assiut University

Unknown

Arthroscopic Evaluation of Cartilage Regeneration After Opening-wedge High Tibial Osteotomy

Osteo Arthritis Knee

Egypt
Geisinger Clinic
National Heart, Lung, and Blood Institute (NHLBI)

Enrolling by invitation

Collaborative Approach to Reach Everyone With Familial Hypercholesterolemia (CARE-FH) (CARE-FH)

Familial Hypercholesterolemia

United States
National Cancer Institute (NCI)
NRG Oncology; Canadian Cancer Trials Group

Active, not recruiting

Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin

Head and Neck Squamous Cell Carcinoma | Oropharyngeal Squamous Cell Carcinoma | Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Stage III Hypopharyngeal Carcinoma AJCC v8 | Stage III Laryngeal Cancer AJCC v8 | Stage III Lip and Oral Cavity Cancer AJCC v8 | Stage... and other conditions

United States, Canada
Mayo Clinic
National Cancer Institute (NCI)

Not yet recruiting

Radioembolization With Tremelimumab and Durvalumab for Locally Advanced Unresectable or Oligo-Metastatic Intrahepatic Cholangiocarcinoma

Stage III Intrahepatic Cholangiocarcinoma AJCC v8 | Stage IV Intrahepatic Cholangiocarcinoma AJCC v8 | Unresectable Intrahepatic Cholangiocarcinoma | Locally Advanced Intrahepatic Cholangiocarcinoma | Oligometastatic Intrahepatic Cholangiocarcinoma

United States
National Cancer Institute (NCI)

Not yet recruiting

A Study Comparing the Combination of Dasatinib and Chemotherapy Treatment With or Without Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or Philadelphia Chromosome-Like (Ph-Like) ABL-Class B-Cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)

Suspended

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Down Syndrome | Recurrent B Acute Lymphoblastic Leukemia

United States, Canada, Puerto Rico, Australia
National Cancer Institute (NCI)

Not yet recruiting

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

B Acute Lymphoblastic Leukemia | Acute Leukemia of Ambiguous Lineage
National Cancer Institute (NCI)

Active, not recruiting

Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia

Recurrent B Acute Lymphoblastic Leukemia

United States, Canada, Puerto Rico, Australia, New Zealand
National Cancer Institute (NCI)

Recruiting

A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia

Down Syndrome | B Acute Lymphoblastic Leukemia | B Lymphoblastic Lymphoma

United States, Puerto Rico, Australia, Canada, New Zealand

Search clinical trials for: Teen Outreach Program with Media Enhancement (TOP4ME)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations